Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 7
2005 10
2006 16
2007 12
2008 17
2009 20
2010 22
2011 22
2012 32
2013 24
2014 29
2015 35
2016 30
2017 39
2018 46
2019 88
2020 116
2021 111
2022 123
2023 115
2024 50

Text availability

Article attribute

Article type

Publication date

Search Results

778 results

Results by year

Filters applied: . Clear all
Page 1
Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.
Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C, Churilov LP, Ferrari SM, Antonelli A. Ragusa F, et al. Among authors: antonelli a. Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101367. doi: 10.1016/j.beem.2019.101367. Epub 2019 Nov 26. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31812326 Review.
Myoinositol in Autoimmune Thyroiditis.
Paparo SR, Ferrari SM, Patrizio A, Elia G, Ragusa F, Botrini C, Balestri E, Guarneri F, Benvenga S, Antonelli A, Fallahi P. Paparo SR, et al. Among authors: antonelli a. Front Endocrinol (Lausanne). 2022 Jun 28;13:930756. doi: 10.3389/fendo.2022.930756. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35837308 Free PMC article. Review.
Neutrophil extracellular traps in cancer.
Cristinziano L, Modestino L, Antonelli A, Marone G, Simon HU, Varricchi G, Galdiero MR. Cristinziano L, et al. Among authors: antonelli a. Semin Cancer Biol. 2022 Feb;79:91-104. doi: 10.1016/j.semcancer.2021.07.011. Epub 2021 Jul 16. Semin Cancer Biol. 2022. PMID: 34280576 Review.
Graves' disease: Epidemiology, genetic and environmental risk factors and viruses.
Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, Patrizio A, Giusti C, Gonnella D, Cristaudo A, Foddis R, Shoenfeld Y, Fallahi P. Antonelli A, et al. Best Pract Res Clin Endocrinol Metab. 2020 Jan;34(1):101387. doi: 10.1016/j.beem.2020.101387. Epub 2020 Feb 4. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32107168 Review.
Gut microbiota and Hashimoto's thyroiditis.
Virili C, Fallahi P, Antonelli A, Benvenga S, Centanni M. Virili C, et al. Among authors: antonelli a. Rev Endocr Metab Disord. 2018 Dec;19(4):293-300. doi: 10.1007/s11154-018-9467-y. Rev Endocr Metab Disord. 2018. PMID: 30294759 Review.
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ. Douglas RS, et al. Among authors: antonelli a. N Engl J Med. 2020 Jan 23;382(4):341-352. doi: 10.1056/NEJMoa1910434. N Engl J Med. 2020. PMID: 31971679 Clinical Trial.
Drug Discovery.
Antonelli A. Antonelli A. Curr Pharm Des. 2022;28(3):179. doi: 10.2174/1381612828666220103172626. Curr Pharm Des. 2022. PMID: 35043756 No abstract available.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ. Douglas RS, et al. Among authors: antonelli a. Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21. Ophthalmology. 2022. PMID: 34688699 Free article. Clinical Trial.
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Fallahi P, et al. Among authors: antonelli a. Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26. Semin Cancer Biol. 2022. PMID: 33249201 Review.
778 results